Volume 5, Number 6—December 1999
Swine as a Potential Reservoir of Shiga Toxin-Producing Escherichia coli O157:H7 in Japan
Highlight and copy the desired format.
|EID||Nakazawa M, Akiba M, Sameshima T. Swine as a Potential Reservoir of Shiga Toxin-Producing Escherichia coli O157:H7 in Japan. Emerg Infect Dis. 1999;5(6):833-834. https://dx.doi.org/10.3201/eid0506.990618|
|AMA||Nakazawa M, Akiba M, Sameshima T. Swine as a Potential Reservoir of Shiga Toxin-Producing Escherichia coli O157:H7 in Japan. Emerging Infectious Diseases. 1999;5(6):833-834. doi:10.3201/eid0506.990618.|
|APA||Nakazawa, M., Akiba, M., & Sameshima, T. (1999). Swine as a Potential Reservoir of Shiga Toxin-Producing Escherichia coli O157:H7 in Japan. Emerging Infectious Diseases, 5(6), 833-834. https://dx.doi.org/10.3201/eid0506.990618.|
To the Editor: Shiga toxin-producing Escherichia coli (STEC) O157:H7 has become a major meat safety issue worldwide. Cattle, an important reservoir of human infection (1), may not be the only source of this organism (2,3). In a survey of pigs in England (4), non-STEC O157 was isolated from four (0.4%) fecal samples collected (after slaughter) from 1,000 pigs. We found that, although an unlikely source of infection for humans, pigs are a potential reservoir of STEC O157:H7 in Japan.
In 1997, there were 14,400 pig farms and 9,823,000 pigs (average 682 per farm) in Japan. Thirty-five (0.24%) of these farms were randomly selected for study, and rectal swabs were taken from 221 healthy pigs during May and June 1997. The average number of animals examined on each farm was 6.3.
Fecal samples were dipped into test tubes containing Cary-Blair transport medium (Nissui, Japan) and kept refrigerated until processing (usually within 48 hours). Swabs were then incubated overnight at 42°C in 10 ml of mEC broth (Kyokuto, Japan) containing 20 µg/ml of novobiocin (Sigma, USA), after which one loop of the broth was spread onto MacConkey sorbitol agar medium (Difco, USA). After overnight incubation at 37°C, sorbitol-negative colonies from the agar plates were tested by slide agglutination with E. coli O157-latex test (Oxoid, UK). Strains that agglutinated were confirmed as E. coli by using the API 20E system (BioMerieux, France). Strains confirmed as E. coli O157 were subcultured in a motility medium for 3 to 4 days to enhance development of flagella, then they were tested by tube agglutination with E. coli H7 antiserum (Denka-seiken, Japan). The swine E. coli O157:H7 isolates were examined by polymerase chain reaction for the presence of Shiga-toxin genes stx1 and stx2 and to elucidate intimin (eaeA) DNA sequences (5), for a plasmid of 92 kb (pO157) by agarose gel electrophoresis (6), and for phage type by the previously described method (7).
Although the numbers sampled were too small to allow comparisons between farms, samples from three (1.4%) apparently healthy pigs (ages: 2, 6, and 9 months) from three farms (8.6%) were positive for STEC O157:H7. The three strains from the pigs were biochemically typical of STEC O157:H7 that did not ferment sorbitol and lacked ß-glucuronidase; agglutinated with E. coli O157-latex and with H7 antiserum; possessed stx1, stx2, and eaeA genes; and harbored pO157 plasmid characteristic of STEC O157:H7. The strains belonged to phage type 21, 37, or 43.
The 1.4% carriage rate of STEC O157:H7 in pigs in this investigation is almost the same as that in cattle in Japan (8), which suggests that STEC O157:H7 strains are probably widespread in Japanese pig populations. The STEC O157-positive pigs were each housed in a concrete-floored pen and kept separate from cattle. Whether these pig isolates are the same as cattle or human isolates needs to be clarified; however, they had the same biochemical and genetic markers as STEC O157:H7 isolated from cattle and humans (6,9). The phage type 21 that we found among pig isolates was also observed in bovine and human STEC O157:H7 isolates in Japan (7). These results suggest that common vehicles for dissemination of the organism may exist.
So far, pork has not been identified as a source of human STEC O157:H7 illness in industrialized countries, but our results indicate that eating pork, contact with pigs, and contamination with pig feces should be considered potential sources of this pathogen. This is the first isolation of naturally occurring STEC O157:H7 in pigs in Japan.
This work was supported by a grant from the Ministry of Agriculture, Forestry, and Fisheries of Japan.
- Wells JG, Shipman LD, Greene KD, Sowers EG, Green JH, Cameron DN, Isolation of Escherichia coli serotype O157:H7 and other shiga-like-toxin-producing E. coli from dairy cattle. J Clin Microbiol. 1991;29:985–9.
- Chapman PA, Siddons CA, Harkin MA. Sheep as a potential source of verocytotoxin-producing Escherichia coli O157. Vet Rec. 1996;138:23–4.
- Chalmers RM, Salmon RL, Willshaw GA, Cheasty T, Looker N, Davies I, Vero-cytotoxin-producing Escherichia coli O157 in a farmer handling horses. Lancet. 1997;349:1816.
- Chapman PA, Siddons CA, Cerdan Malo AT, Harkin MA. A 1-year study of Escherichia coli O157 in cattle, sheep, pigs and poultry. Epidemiol Infect. 1997;119:245–50.
- Sueyoshi M, Fukui H, Tanaka S, Nakazawa M, Ito K. A new adherent form of an attaching and effacing Escherichia coli (eaeA+,bfp-) to the intestinal epithelial cells of chicks. J Vet Med Sci. 1996;58:1145–7.
- Chapman PA, Siddons CA, Wright DJ, Norman P, Fox J, Crick E. Cattle as a possible source of verocytotoxin-producing Escherichia coli O157 infections in man. Epidemiol Infect. 1993;111:439–47.
- Akiba M, Masuda T, Sameshima T, Katsuda K, Nakazawa M. Molecular typing of Escherichia coli O157:H7(H-) isolates from cattle in Japan. Epidemiol Infect. 1999;122:337–41.
- Sekiya J. Escherichia coli O157:H7 in livestock in Japan. Revue Scientifique et Technique Office International des Épizooties. 1997;16:391–4.
- Ratnam S, March SB, Ahmed R, Bezanson GS, Kasatiya S. Characterization of Escherichia coli serotype O157:H7. J Clin Microbiol. 1988;26:2006–12.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: December 16, 2010
- Page last updated: December 16, 2010
- Page last reviewed: December 16, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)